Social

Home page

Social

FDA approves Pfizer, Moderna jabs for children

17 June 2022 18:21 (UTC +04:00)

The United States Food and Drug Administration (FDA) approved on Friday vaccines made by Pfizer/BioNTech for children aged between 6 months and 4 years, and Moderna for use in children from 6 months to 17 years of age, APA reports citing Teletrader.

The Pfizer jab will be administered in three doses, while the Moderna shot will have a two-dose primary series, with a third dose possible for immunocompromised children.

"As with all vaccines for any population, when authorizing COVID-19 vaccines intended for pediatric age groups, the FDA ensures that our evaluation and analysis of the data is rigorous and thorough," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. "In addition to making certain the data for these vaccines met FDA's rigorous standards, the agency’s convening of an advisory committee was part of a transparent process to help the public have a clear understanding of the safety and effectiveness data supporting the authorization of these two vaccines for pediatric populations."